Status:
RECRUITING
Aspire2B Personalization Pilot Study Program
Lead Sponsor:
PepsiCo Global R&D
Conditions:
App Proficiency
Behavior
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This non-randomized pilot study program is focused on assessing the technical characteristics of the Aspire2B mobile device application.
Detailed Description
Aspire2B is a mobile wellness app that uses non-invasive measurements to predict various physiological states and estimate biological age. Users are then enrolled in nutrition, fitness, or sleep chall...
Eligibility Criteria
Inclusion
- Fluent in reading and understanding English or Spanish
- Smartphone users
Exclusion
- Cannot proceed to onboarding without downloading the app, consenting to participate, and agreeing to app Terms of Use
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06191822
Start Date
March 1 2022
End Date
June 30 2024
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Remote, no facility visits. Managed by PepsiCo R&D Life Sciences
Chicago, Illinois, United States, 60661